Joint Canada-Israel Health Research Program

Students working in a public university's laboratory

The Joint Canada-Israel Health Research Program is a seven-year, CA$35 million partnership between IDRC, the Israel Science Foundation, the Azrieli Foundation and the Canadian Institutes of Health Research that draws on the scientific strengths of Canadian and Israeli researchers in the broad field of biomedical science. It is expected to fund up to 30 collaborative projects involving researchers from Canada and Israel, as well as from low and middle-income countries.

The program is currently funding 24 joint projects resulting from the first four calls for proposals:

Selected neurosciences research projects

Neurological disorders are a public health concern that affects hundreds of millions of people globally, according to the World Health Organization. As populations age, neurological disorders will account for a growing portion of the socio-economic burden of disease, particularly in developing countries. Delaying the onset of these diseases, or finding ways to prevent them entirely, can have a significant impact on the well-being and prosperity of individuals and societies.

To help tackle this challenge, the Joint Canada-Israel Health Research Program is supporting six projects led by world-class teams, which were selected from among the 64 proposals submitted to the program’s call in 2015.

Four research teams seek to understand brain functions underlying prevalent neurological conditions such as Alzheimer's disease, Parkinson's disease, brain cancer, mood disorders, and dyslexia. Two other teams are investigating the use of virtual reality and robotics, one in movement recovery among stroke patients, the other in the mechanisms for nerve regeneration after injury.

The following list of projects is in alphabetical order (according to the Canadian nominated principal investigator’s last name).

Researchers : Frédéric Charron (Institut de recherches cliniques de l’Université de Montréal); Avraham Yaron (Weizmann Institute of Science); Felipe A. Court (Universidad de Chile)

Researchers: Paul Forsythe (McMaster University); Omry Koren (Bar-Ilan University); Javier Bravo and Marcela Julio (Pontificia Universidad Católica de Valparaíso)

Researchers: Mindy F. Levin (McGill University); Dario G. Liebermann (Tel Aviv University); John Solomon Manikandan and Natarajan Vasanthan Rajagopalan (Manipal University)

Researchers: Nahum Sonenberg (McGill University); Kobi Rosenblum (University of Haifa); Deepak Nair (Indian Institute of Science)

Researchers: Uri Tabori (Hospital for Sick Children); Gideon Rechavi (Tel Aviv University); Fatiha Gachi (Mustapha Bâcha Hospital); Andrea Cappellano (Federal University of São Paulo); Shadi Fadel (Alexandria University); Brijesh Arora (Tata Memorial Centre); Nisreen Amayiri (King Hussein Cancer Centre)

Researchers: Robert Zatorre (McGill University); Merav Ahissar (Hebrew University of Jerusalem); Nandini C. Singh (National Brain Research Centre)